nodes	percent_of_prediction	percent_of_DWPC	metapath
Mianserin—CYP1A2—Clobetasol propionate—psoriasis	0.112	0.189	CbGbCtD
Mianserin—CYP2B6—Cholecalciferol—psoriasis	0.0668	0.112	CbGbCtD
Mianserin—CYP1A2—Methoxsalen—psoriasis	0.0591	0.0992	CbGbCtD
Mianserin—CYP2D6—Hydroxyurea—psoriasis	0.0532	0.0893	CbGbCtD
Mianserin—CYP3A4—Calcitriol—psoriasis	0.0398	0.0668	CbGbCtD
Mianserin—CYP2D6—Cholecalciferol—psoriasis	0.0323	0.0541	CbGbCtD
Mianserin—CYP3A4—Methoxsalen—psoriasis	0.031	0.052	CbGbCtD
Mianserin—CYP2B6—Dexamethasone—psoriasis	0.0289	0.0485	CbGbCtD
Mianserin—CYP2D6—Cyclosporine—psoriasis	0.0212	0.0356	CbGbCtD
Mianserin—CYP3A4—Cholecalciferol—psoriasis	0.0205	0.0344	CbGbCtD
Mianserin—CYP3A4—Mycophenolate mofetil—psoriasis	0.0178	0.0298	CbGbCtD
Mianserin—CYP3A4—Triamcinolone—psoriasis	0.0178	0.0298	CbGbCtD
Mianserin—CYP3A4—Betamethasone—psoriasis	0.0153	0.0256	CbGbCtD
Mianserin—CYP3A4—Prednisolone—psoriasis	0.0151	0.0253	CbGbCtD
Mianserin—CYP3A4—Hydrocortisone—psoriasis	0.0143	0.024	CbGbCtD
Mianserin—CYP3A4—Prednisone—psoriasis	0.0142	0.0239	CbGbCtD
Mianserin—CYP2D6—Dexamethasone—psoriasis	0.014	0.0234	CbGbCtD
Mianserin—CYP3A4—Cyclosporine—psoriasis	0.0135	0.0226	CbGbCtD
Mianserin—CYP3A4—Dexamethasone—psoriasis	0.00887	0.0149	CbGbCtD
Mianserin—Bradycardia—Betamethasone—psoriasis	0.000511	0.00159	CcSEcCtD
Mianserin—Neutropenia—Prednisone—psoriasis	0.000511	0.00159	CcSEcCtD
Mianserin—Vertigo—Mycophenolate mofetil—psoriasis	0.000505	0.00157	CcSEcCtD
Mianserin—Syncope—Mycophenolate mofetil—psoriasis	0.000504	0.00156	CcSEcCtD
Mianserin—Erectile dysfunction—Prednisone—psoriasis	0.000503	0.00156	CcSEcCtD
Mianserin—Leukopenia—Mycophenolate mofetil—psoriasis	0.000503	0.00156	CcSEcCtD
Mianserin—Gastrointestinal disorder—Mycophenolic acid—psoriasis	0.000501	0.00156	CcSEcCtD
Mianserin—Fatigue—Mycophenolic acid—psoriasis	0.000501	0.00156	CcSEcCtD
Mianserin—Convulsion—Cyclosporine—psoriasis	0.000499	0.00155	CcSEcCtD
Mianserin—Asthenia—Hydroxyurea—psoriasis	0.000498	0.00155	CcSEcCtD
Mianserin—Weight increased—Prednisone—psoriasis	0.000497	0.00154	CcSEcCtD
Mianserin—Hypertension—Cyclosporine—psoriasis	0.000497	0.00154	CcSEcCtD
Mianserin—Constipation—Mycophenolic acid—psoriasis	0.000497	0.00154	CcSEcCtD
Mianserin—Loss of consciousness—Mycophenolate mofetil—psoriasis	0.000494	0.00153	CcSEcCtD
Mianserin—Arthralgia—Cyclosporine—psoriasis	0.00049	0.00152	CcSEcCtD
Mianserin—Myalgia—Cyclosporine—psoriasis	0.00049	0.00152	CcSEcCtD
Mianserin—Unspecified disorder of skin and subcutaneous tissue—Cyclosporine—psoriasis	0.000487	0.00151	CcSEcCtD
Mianserin—Convulsion—Mycophenolate mofetil—psoriasis	0.000487	0.00151	CcSEcCtD
Mianserin—Hypertension—Mycophenolate mofetil—psoriasis	0.000485	0.00151	CcSEcCtD
Mianserin—Dry mouth—Cyclosporine—psoriasis	0.000479	0.00149	CcSEcCtD
Mianserin—Feeling abnormal—Mycophenolic acid—psoriasis	0.000479	0.00149	CcSEcCtD
Mianserin—Arthralgia—Mycophenolate mofetil—psoriasis	0.000478	0.00149	CcSEcCtD
Mianserin—Myalgia—Mycophenolate mofetil—psoriasis	0.000478	0.00149	CcSEcCtD
Mianserin—Breast disorder—Methotrexate—psoriasis	0.000477	0.00148	CcSEcCtD
Mianserin—Unspecified disorder of skin and subcutaneous tissue—Mycophenolate mofetil—psoriasis	0.000475	0.00147	CcSEcCtD
Mianserin—Confusional state—Cyclosporine—psoriasis	0.000474	0.00147	CcSEcCtD
Mianserin—Vertigo—Prednisolone—psoriasis	0.000471	0.00146	CcSEcCtD
Mianserin—Oedema—Cyclosporine—psoriasis	0.00047	0.00146	CcSEcCtD
Mianserin—Syncope—Prednisolone—psoriasis	0.00047	0.00146	CcSEcCtD
Mianserin—Eye disorder—Dexamethasone—psoriasis	0.000469	0.00146	CcSEcCtD
Mianserin—Eye disorder—Betamethasone—psoriasis	0.000469	0.00146	CcSEcCtD
Mianserin—Dry mouth—Mycophenolate mofetil—psoriasis	0.000468	0.00145	CcSEcCtD
Mianserin—Confusional state—Mycophenolate mofetil—psoriasis	0.000462	0.00144	CcSEcCtD
Mianserin—Nervous system disorder—Cyclosporine—psoriasis	0.000461	0.00143	CcSEcCtD
Mianserin—Loss of consciousness—Prednisolone—psoriasis	0.00046	0.00143	CcSEcCtD
Mianserin—Thrombocytopenia—Cyclosporine—psoriasis	0.00046	0.00143	CcSEcCtD
Mianserin—Vertigo—Hydrocortisone—psoriasis	0.00046	0.00143	CcSEcCtD
Mianserin—Syncope—Hydrocortisone—psoriasis	0.000459	0.00143	CcSEcCtD
Mianserin—Dizziness—Hydroxyurea—psoriasis	0.000459	0.00142	CcSEcCtD
Mianserin—Oedema—Mycophenolate mofetil—psoriasis	0.000458	0.00142	CcSEcCtD
Mianserin—Skin disorder—Cyclosporine—psoriasis	0.000456	0.00142	CcSEcCtD
Mianserin—Angiopathy—Betamethasone—psoriasis	0.000456	0.00142	CcSEcCtD
Mianserin—Angiopathy—Dexamethasone—psoriasis	0.000456	0.00142	CcSEcCtD
Mianserin—Convulsion—Prednisolone—psoriasis	0.000454	0.00141	CcSEcCtD
Mianserin—Hypertension—Prednisolone—psoriasis	0.000452	0.0014	CcSEcCtD
Mianserin—Shock—Mycophenolate mofetil—psoriasis	0.000451	0.0014	CcSEcCtD
Mianserin—Loss of consciousness—Hydrocortisone—psoriasis	0.00045	0.0014	CcSEcCtD
Mianserin—Nervous system disorder—Mycophenolate mofetil—psoriasis	0.000449	0.0014	CcSEcCtD
Mianserin—Thrombocytopenia—Mycophenolate mofetil—psoriasis	0.000449	0.00139	CcSEcCtD
Mianserin—Tachycardia—Mycophenolate mofetil—psoriasis	0.000447	0.00139	CcSEcCtD
Mianserin—Skin disorder—Mycophenolate mofetil—psoriasis	0.000445	0.00138	CcSEcCtD
Mianserin—Bradycardia—Prednisone—psoriasis	0.000445	0.00138	CcSEcCtD
Mianserin—Convulsion—Hydrocortisone—psoriasis	0.000443	0.00138	CcSEcCtD
Mianserin—Hypertension—Hydrocortisone—psoriasis	0.000442	0.00137	CcSEcCtD
Mianserin—Rash—Hydroxyurea—psoriasis	0.000437	0.00136	CcSEcCtD
Mianserin—Dermatitis—Hydroxyurea—psoriasis	0.000437	0.00136	CcSEcCtD
Mianserin—Myalgia—Hydrocortisone—psoriasis	0.000436	0.00135	CcSEcCtD
Mianserin—Headache—Hydroxyurea—psoriasis	0.000434	0.00135	CcSEcCtD
Mianserin—Pancytopenia—Methotrexate—psoriasis	0.000434	0.00135	CcSEcCtD
Mianserin—Vertigo—Triamcinolone—psoriasis	0.000433	0.00134	CcSEcCtD
Mianserin—Unspecified disorder of skin and subcutaneous tissue—Hydrocortisone—psoriasis	0.000433	0.00134	CcSEcCtD
Mianserin—Syncope—Triamcinolone—psoriasis	0.000432	0.00134	CcSEcCtD
Mianserin—Connective tissue disorder—Prednisone—psoriasis	0.00043	0.00133	CcSEcCtD
Mianserin—Hypotension—Mycophenolate mofetil—psoriasis	0.000428	0.00133	CcSEcCtD
Mianserin—Musculoskeletal discomfort—Cyclosporine—psoriasis	0.000428	0.00133	CcSEcCtD
Mianserin—Oedema—Prednisolone—psoriasis	0.000428	0.00133	CcSEcCtD
Mianserin—Neutropenia—Methotrexate—psoriasis	0.000427	0.00133	CcSEcCtD
Mianserin—Loss of consciousness—Triamcinolone—psoriasis	0.000423	0.00132	CcSEcCtD
Mianserin—Paraesthesia—Cyclosporine—psoriasis	0.000422	0.00131	CcSEcCtD
Mianserin—Shock—Prednisolone—psoriasis	0.000421	0.00131	CcSEcCtD
Mianserin—Erectile dysfunction—Methotrexate—psoriasis	0.000421	0.00131	CcSEcCtD
Mianserin—Somnolence—Cyclosporine—psoriasis	0.000418	0.0013	CcSEcCtD
Mianserin—Musculoskeletal discomfort—Mycophenolate mofetil—psoriasis	0.000418	0.0013	CcSEcCtD
Mianserin—Oedema—Hydrocortisone—psoriasis	0.000418	0.0013	CcSEcCtD
Mianserin—Convulsion—Triamcinolone—psoriasis	0.000417	0.0013	CcSEcCtD
Mianserin—Tachycardia—Prednisolone—psoriasis	0.000417	0.0013	CcSEcCtD
Mianserin—Asthenia—Mycophenolic acid—psoriasis	0.000417	0.00129	CcSEcCtD
Mianserin—Hypertension—Triamcinolone—psoriasis	0.000416	0.00129	CcSEcCtD
Mianserin—Paraesthesia—Mycophenolate mofetil—psoriasis	0.000412	0.00128	CcSEcCtD
Mianserin—Pruritus—Mycophenolic acid—psoriasis	0.000411	0.00128	CcSEcCtD
Mianserin—Shock—Hydrocortisone—psoriasis	0.000411	0.00128	CcSEcCtD
Mianserin—Myalgia—Triamcinolone—psoriasis	0.00041	0.00127	CcSEcCtD
Mianserin—Nervous system disorder—Hydrocortisone—psoriasis	0.000409	0.00127	CcSEcCtD
Mianserin—Eye disorder—Prednisone—psoriasis	0.000409	0.00127	CcSEcCtD
Mianserin—Tachycardia—Hydrocortisone—psoriasis	0.000408	0.00127	CcSEcCtD
Mianserin—Somnolence—Mycophenolate mofetil—psoriasis	0.000407	0.00127	CcSEcCtD
Mianserin—Drowsiness—Methotrexate—psoriasis	0.000407	0.00126	CcSEcCtD
Mianserin—Gastrointestinal disorder—Cyclosporine—psoriasis	0.000406	0.00126	CcSEcCtD
Mianserin—Skin disorder—Hydrocortisone—psoriasis	0.000406	0.00126	CcSEcCtD
Mianserin—Fatigue—Cyclosporine—psoriasis	0.000405	0.00126	CcSEcCtD
Mianserin—Constipation—Cyclosporine—psoriasis	0.000402	0.00125	CcSEcCtD
Mianserin—Dry mouth—Triamcinolone—psoriasis	0.000401	0.00125	CcSEcCtD
Mianserin—Angiopathy—Prednisone—psoriasis	0.000397	0.00123	CcSEcCtD
Mianserin—Gastrointestinal disorder—Mycophenolate mofetil—psoriasis	0.000396	0.00123	CcSEcCtD
Mianserin—Oedema—Triamcinolone—psoriasis	0.000393	0.00122	CcSEcCtD
Mianserin—Vertigo—Dexamethasone—psoriasis	0.000393	0.00122	CcSEcCtD
Mianserin—Vertigo—Betamethasone—psoriasis	0.000393	0.00122	CcSEcCtD
Mianserin—Syncope—Dexamethasone—psoriasis	0.000392	0.00122	CcSEcCtD
Mianserin—Syncope—Betamethasone—psoriasis	0.000392	0.00122	CcSEcCtD
Mianserin—Constipation—Mycophenolate mofetil—psoriasis	0.000392	0.00122	CcSEcCtD
Mianserin—Hypotension—Hydrocortisone—psoriasis	0.00039	0.00121	CcSEcCtD
Mianserin—Feeling abnormal—Cyclosporine—psoriasis	0.000387	0.0012	CcSEcCtD
Mianserin—Shock—Triamcinolone—psoriasis	0.000387	0.0012	CcSEcCtD
Mianserin—Hepatobiliary disease—Methotrexate—psoriasis	0.000385	0.0012	CcSEcCtD
Mianserin—Loss of consciousness—Betamethasone—psoriasis	0.000384	0.00119	CcSEcCtD
Mianserin—Loss of consciousness—Dexamethasone—psoriasis	0.000384	0.00119	CcSEcCtD
Mianserin—Dizziness—Mycophenolic acid—psoriasis	0.000384	0.00119	CcSEcCtD
Mianserin—Paraesthesia—Prednisolone—psoriasis	0.000384	0.00119	CcSEcCtD
Mianserin—Tachycardia—Triamcinolone—psoriasis	0.000384	0.00119	CcSEcCtD
Mianserin—Mental disorder—Prednisone—psoriasis	0.000383	0.00119	CcSEcCtD
Mianserin—Musculoskeletal discomfort—Hydrocortisone—psoriasis	0.00038	0.00118	CcSEcCtD
Mianserin—Agranulocytosis—Methotrexate—psoriasis	0.00038	0.00118	CcSEcCtD
Mianserin—Convulsion—Dexamethasone—psoriasis	0.000379	0.00118	CcSEcCtD
Mianserin—Convulsion—Betamethasone—psoriasis	0.000379	0.00118	CcSEcCtD
Mianserin—Feeling abnormal—Mycophenolate mofetil—psoriasis	0.000378	0.00117	CcSEcCtD
Mianserin—Hypertension—Betamethasone—psoriasis	0.000377	0.00117	CcSEcCtD
Mianserin—Hypertension—Dexamethasone—psoriasis	0.000377	0.00117	CcSEcCtD
Mianserin—Paraesthesia—Hydrocortisone—psoriasis	0.000375	0.00116	CcSEcCtD
Mianserin—Myalgia—Dexamethasone—psoriasis	0.000372	0.00116	CcSEcCtD
Mianserin—Myalgia—Betamethasone—psoriasis	0.000372	0.00116	CcSEcCtD
Mianserin—Rash—Mycophenolic acid—psoriasis	0.000366	0.00114	CcSEcCtD
Mianserin—Dermatitis—Mycophenolic acid—psoriasis	0.000366	0.00114	CcSEcCtD
Mianserin—Hepatitis—Methotrexate—psoriasis	0.000365	0.00114	CcSEcCtD
Mianserin—Headache—Mycophenolic acid—psoriasis	0.000364	0.00113	CcSEcCtD
Mianserin—Gastrointestinal disorder—Hydrocortisone—psoriasis	0.00036	0.00112	CcSEcCtD
Mianserin—Fatigue—Hydrocortisone—psoriasis	0.00036	0.00112	CcSEcCtD
Mianserin—Musculoskeletal discomfort—Triamcinolone—psoriasis	0.000358	0.00111	CcSEcCtD
Mianserin—Oedema—Dexamethasone—psoriasis	0.000357	0.00111	CcSEcCtD
Mianserin—Oedema—Betamethasone—psoriasis	0.000357	0.00111	CcSEcCtD
Mianserin—Paraesthesia—Triamcinolone—psoriasis	0.000353	0.0011	CcSEcCtD
Mianserin—Feeling abnormal—Prednisolone—psoriasis	0.000352	0.00109	CcSEcCtD
Mianserin—Anaemia—Prednisone—psoriasis	0.000352	0.00109	CcSEcCtD
Mianserin—Shock—Dexamethasone—psoriasis	0.000351	0.00109	CcSEcCtD
Mianserin—Shock—Betamethasone—psoriasis	0.000351	0.00109	CcSEcCtD
Mianserin—Nervous system disorder—Betamethasone—psoriasis	0.00035	0.00109	CcSEcCtD
Mianserin—Nervous system disorder—Dexamethasone—psoriasis	0.00035	0.00109	CcSEcCtD
Mianserin—Agitation—Prednisone—psoriasis	0.00035	0.00109	CcSEcCtD
Mianserin—Thrombocytopenia—Betamethasone—psoriasis	0.000349	0.00108	CcSEcCtD
Mianserin—Thrombocytopenia—Dexamethasone—psoriasis	0.000349	0.00108	CcSEcCtD
Mianserin—Tachycardia—Dexamethasone—psoriasis	0.000348	0.00108	CcSEcCtD
Mianserin—Tachycardia—Betamethasone—psoriasis	0.000348	0.00108	CcSEcCtD
Mianserin—Feeling abnormal—Hydrocortisone—psoriasis	0.000344	0.00107	CcSEcCtD
Mianserin—Vertigo—Prednisone—psoriasis	0.000342	0.00106	CcSEcCtD
Mianserin—Eye disorder—Methotrexate—psoriasis	0.000342	0.00106	CcSEcCtD
Mianserin—Syncope—Prednisone—psoriasis	0.000341	0.00106	CcSEcCtD
Mianserin—Tinnitus—Methotrexate—psoriasis	0.000341	0.00106	CcSEcCtD
Mianserin—Cardiac disorder—Methotrexate—psoriasis	0.000339	0.00105	CcSEcCtD
Mianserin—Fatigue—Triamcinolone—psoriasis	0.000339	0.00105	CcSEcCtD
Mianserin—Asthenia—Cyclosporine—psoriasis	0.000337	0.00105	CcSEcCtD
Mianserin—Loss of consciousness—Prednisone—psoriasis	0.000335	0.00104	CcSEcCtD
Mianserin—Hypotension—Betamethasone—psoriasis	0.000333	0.00104	CcSEcCtD
Mianserin—Hypotension—Dexamethasone—psoriasis	0.000333	0.00104	CcSEcCtD
Mianserin—Pruritus—Cyclosporine—psoriasis	0.000332	0.00103	CcSEcCtD
Mianserin—Angiopathy—Methotrexate—psoriasis	0.000332	0.00103	CcSEcCtD
Mianserin—Convulsion—Prednisone—psoriasis	0.00033	0.00102	CcSEcCtD
Mianserin—Mediastinal disorder—Methotrexate—psoriasis	0.000329	0.00102	CcSEcCtD
Mianserin—Asthenia—Mycophenolate mofetil—psoriasis	0.000329	0.00102	CcSEcCtD
Mianserin—Hypertension—Prednisone—psoriasis	0.000329	0.00102	CcSEcCtD
Mianserin—Musculoskeletal discomfort—Dexamethasone—psoriasis	0.000325	0.00101	CcSEcCtD
Mianserin—Musculoskeletal discomfort—Betamethasone—psoriasis	0.000325	0.00101	CcSEcCtD
Mianserin—Pruritus—Mycophenolate mofetil—psoriasis	0.000324	0.00101	CcSEcCtD
Mianserin—Arthralgia—Prednisone—psoriasis	0.000324	0.00101	CcSEcCtD
Mianserin—Myalgia—Prednisone—psoriasis	0.000324	0.00101	CcSEcCtD
Mianserin—Feeling abnormal—Triamcinolone—psoriasis	0.000324	0.00101	CcSEcCtD
Mianserin—Unspecified disorder of skin and subcutaneous tissue—Prednisone—psoriasis	0.000322	0.001	CcSEcCtD
Mianserin—Paraesthesia—Dexamethasone—psoriasis	0.00032	0.000995	CcSEcCtD
Mianserin—Paraesthesia—Betamethasone—psoriasis	0.00032	0.000995	CcSEcCtD
Mianserin—Mental disorder—Methotrexate—psoriasis	0.00032	0.000995	CcSEcCtD
Mianserin—Dizziness—Cyclosporine—psoriasis	0.000311	0.000965	CcSEcCtD
Mianserin—Oedema—Prednisone—psoriasis	0.000311	0.000965	CcSEcCtD
Mianserin—Gastrointestinal disorder—Betamethasone—psoriasis	0.000308	0.000957	CcSEcCtD
Mianserin—Gastrointestinal disorder—Dexamethasone—psoriasis	0.000308	0.000957	CcSEcCtD
Mianserin—Fatigue—Dexamethasone—psoriasis	0.000308	0.000955	CcSEcCtD
Mianserin—Fatigue—Betamethasone—psoriasis	0.000308	0.000955	CcSEcCtD
Mianserin—Shock—Prednisone—psoriasis	0.000306	0.000949	CcSEcCtD
Mianserin—Nervous system disorder—Prednisone—psoriasis	0.000305	0.000946	CcSEcCtD
Mianserin—Tachycardia—Prednisone—psoriasis	0.000303	0.000942	CcSEcCtD
Mianserin—Dizziness—Mycophenolate mofetil—psoriasis	0.000303	0.000941	CcSEcCtD
Mianserin—Skin disorder—Prednisone—psoriasis	0.000302	0.000937	CcSEcCtD
Mianserin—Asthenia—Hydrocortisone—psoriasis	0.0003	0.000931	CcSEcCtD
Mianserin—Rash—Cyclosporine—psoriasis	0.000296	0.00092	CcSEcCtD
Mianserin—Dermatitis—Cyclosporine—psoriasis	0.000296	0.000919	CcSEcCtD
Mianserin—Pruritus—Hydrocortisone—psoriasis	0.000295	0.000918	CcSEcCtD
Mianserin—Headache—Cyclosporine—psoriasis	0.000294	0.000914	CcSEcCtD
Mianserin—Anaemia—Methotrexate—psoriasis	0.000294	0.000913	CcSEcCtD
Mianserin—Feeling abnormal—Betamethasone—psoriasis	0.000294	0.000913	CcSEcCtD
Mianserin—Feeling abnormal—Dexamethasone—psoriasis	0.000294	0.000913	CcSEcCtD
Mianserin—Rash—Mycophenolate mofetil—psoriasis	0.000289	0.000898	CcSEcCtD
Mianserin—Dermatitis—Mycophenolate mofetil—psoriasis	0.000289	0.000897	CcSEcCtD
Mianserin—Headache—Mycophenolate mofetil—psoriasis	0.000287	0.000892	CcSEcCtD
Mianserin—Vertigo—Methotrexate—psoriasis	0.000286	0.000888	CcSEcCtD
Mianserin—Leukopenia—Methotrexate—psoriasis	0.000285	0.000885	CcSEcCtD
Mianserin—Musculoskeletal discomfort—Prednisone—psoriasis	0.000283	0.000879	CcSEcCtD
Mianserin—Dizziness—Prednisolone—psoriasis	0.000283	0.000878	CcSEcCtD
Mianserin—Asthenia—Triamcinolone—psoriasis	0.000282	0.000876	CcSEcCtD
Mianserin—Paraesthesia—Prednisone—psoriasis	0.000279	0.000867	CcSEcCtD
Mianserin—Pruritus—Triamcinolone—psoriasis	0.000278	0.000864	CcSEcCtD
Mianserin—Dizziness—Hydrocortisone—psoriasis	0.000276	0.000858	CcSEcCtD
Mianserin—Convulsion—Methotrexate—psoriasis	0.000276	0.000856	CcSEcCtD
Mianserin—Arthralgia—Methotrexate—psoriasis	0.000271	0.000841	CcSEcCtD
Mianserin—Myalgia—Methotrexate—psoriasis	0.000271	0.000841	CcSEcCtD
Mianserin—Rash—Prednisolone—psoriasis	0.00027	0.000837	CcSEcCtD
Mianserin—Dermatitis—Prednisolone—psoriasis	0.000269	0.000837	CcSEcCtD
Mianserin—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—psoriasis	0.000269	0.000836	CcSEcCtD
Mianserin—Fatigue—Prednisone—psoriasis	0.000268	0.000832	CcSEcCtD
Mianserin—Headache—Prednisolone—psoriasis	0.000268	0.000832	CcSEcCtD
Mianserin—Constipation—Prednisone—psoriasis	0.000266	0.000825	CcSEcCtD
Mianserin—Rash—Hydrocortisone—psoriasis	0.000263	0.000818	CcSEcCtD
Mianserin—Dermatitis—Hydrocortisone—psoriasis	0.000263	0.000817	CcSEcCtD
Mianserin—Confusional state—Methotrexate—psoriasis	0.000262	0.000813	CcSEcCtD
Mianserin—Headache—Hydrocortisone—psoriasis	0.000262	0.000813	CcSEcCtD
Mianserin—Dizziness—Triamcinolone—psoriasis	0.00026	0.000808	CcSEcCtD
Mianserin—Feeling abnormal—Prednisone—psoriasis	0.000256	0.000795	CcSEcCtD
Mianserin—Asthenia—Dexamethasone—psoriasis	0.000256	0.000795	CcSEcCtD
Mianserin—Asthenia—Betamethasone—psoriasis	0.000256	0.000795	CcSEcCtD
Mianserin—Nervous system disorder—Methotrexate—psoriasis	0.000255	0.000791	CcSEcCtD
Mianserin—Thrombocytopenia—Methotrexate—psoriasis	0.000254	0.00079	CcSEcCtD
Mianserin—Pruritus—Dexamethasone—psoriasis	0.000252	0.000784	CcSEcCtD
Mianserin—Pruritus—Betamethasone—psoriasis	0.000252	0.000784	CcSEcCtD
Mianserin—Skin disorder—Methotrexate—psoriasis	0.000252	0.000783	CcSEcCtD
Mianserin—Rash—Triamcinolone—psoriasis	0.000248	0.00077	CcSEcCtD
Mianserin—Dermatitis—Triamcinolone—psoriasis	0.000248	0.000769	CcSEcCtD
Mianserin—Headache—Triamcinolone—psoriasis	0.000246	0.000765	CcSEcCtD
Mianserin—Hypotension—Methotrexate—psoriasis	0.000243	0.000754	CcSEcCtD
Mianserin—Musculoskeletal discomfort—Methotrexate—psoriasis	0.000237	0.000735	CcSEcCtD
Mianserin—Dizziness—Betamethasone—psoriasis	0.000236	0.000733	CcSEcCtD
Mianserin—Dizziness—Dexamethasone—psoriasis	0.000236	0.000733	CcSEcCtD
Mianserin—Paraesthesia—Methotrexate—psoriasis	0.000233	0.000724	CcSEcCtD
Mianserin—Somnolence—Methotrexate—psoriasis	0.000231	0.000717	CcSEcCtD
Mianserin—Rash—Dexamethasone—psoriasis	0.000225	0.000699	CcSEcCtD
Mianserin—Rash—Betamethasone—psoriasis	0.000225	0.000699	CcSEcCtD
Mianserin—Dermatitis—Betamethasone—psoriasis	0.000225	0.000698	CcSEcCtD
Mianserin—Dermatitis—Dexamethasone—psoriasis	0.000225	0.000698	CcSEcCtD
Mianserin—Gastrointestinal disorder—Methotrexate—psoriasis	0.000224	0.000696	CcSEcCtD
Mianserin—Fatigue—Methotrexate—psoriasis	0.000224	0.000695	CcSEcCtD
Mianserin—Headache—Betamethasone—psoriasis	0.000223	0.000694	CcSEcCtD
Mianserin—Headache—Dexamethasone—psoriasis	0.000223	0.000694	CcSEcCtD
Mianserin—Asthenia—Prednisone—psoriasis	0.000223	0.000692	CcSEcCtD
Mianserin—Pruritus—Prednisone—psoriasis	0.00022	0.000683	CcSEcCtD
Mianserin—Feeling abnormal—Methotrexate—psoriasis	0.000214	0.000665	CcSEcCtD
Mianserin—Dizziness—Prednisone—psoriasis	0.000205	0.000638	CcSEcCtD
Mianserin—Rash—Prednisone—psoriasis	0.000196	0.000608	CcSEcCtD
Mianserin—Dermatitis—Prednisone—psoriasis	0.000196	0.000608	CcSEcCtD
Mianserin—Headache—Prednisone—psoriasis	0.000195	0.000605	CcSEcCtD
Mianserin—Asthenia—Methotrexate—psoriasis	0.000186	0.000579	CcSEcCtD
Mianserin—Pruritus—Methotrexate—psoriasis	0.000184	0.000571	CcSEcCtD
Mianserin—Dizziness—Methotrexate—psoriasis	0.000172	0.000533	CcSEcCtD
Mianserin—Rash—Methotrexate—psoriasis	0.000164	0.000509	CcSEcCtD
Mianserin—Dermatitis—Methotrexate—psoriasis	0.000164	0.000508	CcSEcCtD
Mianserin—Headache—Methotrexate—psoriasis	0.000163	0.000505	CcSEcCtD
Mianserin—HRH4—Signaling Pathways—JUN—psoriasis	2.13e-05	0.00026	CbGpPWpGaD
Mianserin—HTR1F—Signaling Pathways—CXCL8—psoriasis	2.12e-05	0.000258	CbGpPWpGaD
Mianserin—HTR2B—Signaling by GPCR—CXCL8—psoriasis	2.11e-05	0.000257	CbGpPWpGaD
Mianserin—OPRK1—Signaling Pathways—APOE—psoriasis	2.09e-05	0.000254	CbGpPWpGaD
Mianserin—OPRK1—Signaling Pathways—LEP—psoriasis	2.09e-05	0.000254	CbGpPWpGaD
Mianserin—HTR1A—Signaling Pathways—SOCS1—psoriasis	2.06e-05	0.000251	CbGpPWpGaD
Mianserin—HTR6—Signaling Pathways—LEP—psoriasis	2.06e-05	0.00025	CbGpPWpGaD
Mianserin—HTR6—Signaling Pathways—APOE—psoriasis	2.06e-05	0.00025	CbGpPWpGaD
Mianserin—HRH4—Signaling Pathways—NFKB1—psoriasis	2.06e-05	0.00025	CbGpPWpGaD
Mianserin—HTR7—Signaling Pathways—LEP—psoriasis	2.05e-05	0.00025	CbGpPWpGaD
Mianserin—HTR7—Signaling Pathways—APOE—psoriasis	2.05e-05	0.00025	CbGpPWpGaD
Mianserin—HTR2C—Signaling Pathways—SOCS1—psoriasis	2.05e-05	0.000249	CbGpPWpGaD
Mianserin—HRH2—Signaling Pathways—TYK2—psoriasis	2.05e-05	0.000249	CbGpPWpGaD
Mianserin—HTR1D—Signaling Pathways—LEP—psoriasis	2.04e-05	0.000248	CbGpPWpGaD
Mianserin—HTR1D—Signaling Pathways—APOE—psoriasis	2.04e-05	0.000248	CbGpPWpGaD
Mianserin—ADRA2B—Signaling by GPCR—TYK2—psoriasis	2.04e-05	0.000248	CbGpPWpGaD
Mianserin—HTR1F—Signaling by GPCR—IL6—psoriasis	2.02e-05	0.000245	CbGpPWpGaD
Mianserin—ADRA2C—Signaling Pathways—SOCS1—psoriasis	1.99e-05	0.000243	CbGpPWpGaD
Mianserin—HTR1F—Signaling Pathways—JUN—psoriasis	1.97e-05	0.00024	CbGpPWpGaD
Mianserin—HTR1A—Signaling by GPCR—TYK2—psoriasis	1.97e-05	0.000239	CbGpPWpGaD
Mianserin—DRD3—Signaling by GPCR—CXCL8—psoriasis	1.96e-05	0.000239	CbGpPWpGaD
Mianserin—HTR2C—Signaling by GPCR—TYK2—psoriasis	1.96e-05	0.000238	CbGpPWpGaD
Mianserin—ADRA2B—GPCR downstream signaling—CXCL8—psoriasis	1.95e-05	0.000237	CbGpPWpGaD
Mianserin—CYP2D6—Metabolism—CARM1—psoriasis	1.95e-05	0.000237	CbGpPWpGaD
Mianserin—OPRK1—Signaling Pathways—NFKBIA—psoriasis	1.94e-05	0.000236	CbGpPWpGaD
Mianserin—HTR6—Signaling Pathways—NFKBIA—psoriasis	1.91e-05	0.000233	CbGpPWpGaD
Mianserin—HTR7—Signaling Pathways—NFKBIA—psoriasis	1.91e-05	0.000233	CbGpPWpGaD
Mianserin—ADRA2A—Hemostasis—VEGFA—psoriasis	1.9e-05	0.000231	CbGpPWpGaD
Mianserin—ADRA2C—Signaling by GPCR—TYK2—psoriasis	1.9e-05	0.000231	CbGpPWpGaD
Mianserin—HTR1D—Signaling Pathways—NFKBIA—psoriasis	1.9e-05	0.000231	CbGpPWpGaD
Mianserin—HTR1F—Signaling Pathways—NFKB1—psoriasis	1.9e-05	0.000231	CbGpPWpGaD
Mianserin—ADRA2B—Hemostasis—TP53—psoriasis	1.9e-05	0.00023	CbGpPWpGaD
Mianserin—HTR1A—GPCR downstream signaling—CXCL8—psoriasis	1.88e-05	0.000229	CbGpPWpGaD
Mianserin—HTR2B—Signaling Pathways—LEP—psoriasis	1.88e-05	0.000228	CbGpPWpGaD
Mianserin—HTR2B—Signaling Pathways—APOE—psoriasis	1.88e-05	0.000228	CbGpPWpGaD
Mianserin—HTR2C—GPCR downstream signaling—CXCL8—psoriasis	1.87e-05	0.000228	CbGpPWpGaD
Mianserin—HRH4—Signaling Pathways—VEGFA—psoriasis	1.87e-05	0.000227	CbGpPWpGaD
Mianserin—HRH4—Signaling Pathways—STAT3—psoriasis	1.85e-05	0.000225	CbGpPWpGaD
Mianserin—ADRA2A—Metabolism—CAT—psoriasis	1.84e-05	0.000224	CbGpPWpGaD
Mianserin—ADRA2C—GPCR downstream signaling—CXCL8—psoriasis	1.82e-05	0.000222	CbGpPWpGaD
Mianserin—DRD2—Signaling Pathways—SOCS1—psoriasis	1.81e-05	0.00022	CbGpPWpGaD
Mianserin—HTR2A—Signaling Pathways—SOCS1—psoriasis	1.78e-05	0.000217	CbGpPWpGaD
Mianserin—HRH2—Signaling Pathways—CXCL8—psoriasis	1.78e-05	0.000216	CbGpPWpGaD
Mianserin—HRH1—Signaling Pathways—SOCS1—psoriasis	1.78e-05	0.000216	CbGpPWpGaD
Mianserin—ADRA2B—Signaling by GPCR—CXCL8—psoriasis	1.77e-05	0.000216	CbGpPWpGaD
Mianserin—CYP1A2—Metabolism of lipids and lipoproteins—APOE—psoriasis	1.77e-05	0.000215	CbGpPWpGaD
Mianserin—ADRA2C—Hemostasis—TP53—psoriasis	1.77e-05	0.000215	CbGpPWpGaD
Mianserin—ADRA2C—Metabolism—APOE—psoriasis	1.76e-05	0.000214	CbGpPWpGaD
Mianserin—HTR2B—Signaling Pathways—NFKBIA—psoriasis	1.75e-05	0.000213	CbGpPWpGaD
Mianserin—DRD3—Signaling Pathways—APOE—psoriasis	1.75e-05	0.000212	CbGpPWpGaD
Mianserin—DRD3—Signaling Pathways—LEP—psoriasis	1.75e-05	0.000212	CbGpPWpGaD
Mianserin—DRD2—Signaling by GPCR—TYK2—psoriasis	1.73e-05	0.00021	CbGpPWpGaD
Mianserin—CYP2B6—Metabolism—CAT—psoriasis	1.73e-05	0.00021	CbGpPWpGaD
Mianserin—HTR1F—Signaling Pathways—VEGFA—psoriasis	1.72e-05	0.000209	CbGpPWpGaD
Mianserin—HTR1A—Signaling by GPCR—CXCL8—psoriasis	1.71e-05	0.000208	CbGpPWpGaD
Mianserin—HTR1F—Signaling Pathways—STAT3—psoriasis	1.7e-05	0.000207	CbGpPWpGaD
Mianserin—HTR2C—Signaling by GPCR—CXCL8—psoriasis	1.7e-05	0.000207	CbGpPWpGaD
Mianserin—HTR2A—Signaling by GPCR—TYK2—psoriasis	1.7e-05	0.000206	CbGpPWpGaD
Mianserin—HRH1—Signaling by GPCR—TYK2—psoriasis	1.69e-05	0.000206	CbGpPWpGaD
Mianserin—HRH2—Signaling by GPCR—IL6—psoriasis	1.69e-05	0.000206	CbGpPWpGaD
Mianserin—ADRA2C—Signaling by GPCR—CXCL8—psoriasis	1.66e-05	0.000201	CbGpPWpGaD
Mianserin—HRH2—Signaling Pathways—JUN—psoriasis	1.66e-05	0.000201	CbGpPWpGaD
Mianserin—DRD2—GPCR downstream signaling—CXCL8—psoriasis	1.65e-05	0.000201	CbGpPWpGaD
Mianserin—CYP1A2—Metabolism—CARM1—psoriasis	1.65e-05	0.000201	CbGpPWpGaD
Mianserin—HTR2A—GPCR downstream signaling—CXCL8—psoriasis	1.63e-05	0.000198	CbGpPWpGaD
Mianserin—DRD3—Signaling Pathways—NFKBIA—psoriasis	1.63e-05	0.000198	CbGpPWpGaD
Mianserin—HRH1—GPCR downstream signaling—CXCL8—psoriasis	1.62e-05	0.000197	CbGpPWpGaD
Mianserin—ADRA2A—Signaling Pathways—SOCS1—psoriasis	1.62e-05	0.000197	CbGpPWpGaD
Mianserin—HRH2—Signaling Pathways—NFKB1—psoriasis	1.59e-05	0.000194	CbGpPWpGaD
Mianserin—OPRK1—Signaling Pathways—TYK2—psoriasis	1.59e-05	0.000193	CbGpPWpGaD
Mianserin—ADRA2B—Signaling Pathways—LEP—psoriasis	1.58e-05	0.000192	CbGpPWpGaD
Mianserin—ADRA2B—Signaling Pathways—APOE—psoriasis	1.58e-05	0.000192	CbGpPWpGaD
Mianserin—HTR6—Signaling Pathways—TYK2—psoriasis	1.57e-05	0.000191	CbGpPWpGaD
Mianserin—HTR7—Signaling Pathways—TYK2—psoriasis	1.57e-05	0.00019	CbGpPWpGaD
Mianserin—HTR1D—Signaling Pathways—TYK2—psoriasis	1.56e-05	0.000189	CbGpPWpGaD
Mianserin—ADRA2A—Signaling by GPCR—TYK2—psoriasis	1.54e-05	0.000188	CbGpPWpGaD
Mianserin—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—psoriasis	1.54e-05	0.000188	CbGpPWpGaD
Mianserin—ADRA2C—Metabolism—PPARG—psoriasis	1.53e-05	0.000186	CbGpPWpGaD
Mianserin—HTR1A—Signaling Pathways—LEP—psoriasis	1.52e-05	0.000185	CbGpPWpGaD
Mianserin—HTR1A—Signaling Pathways—APOE—psoriasis	1.52e-05	0.000185	CbGpPWpGaD
Mianserin—HTR2C—Signaling Pathways—LEP—psoriasis	1.51e-05	0.000184	CbGpPWpGaD
Mianserin—HTR2C—Signaling Pathways—APOE—psoriasis	1.51e-05	0.000184	CbGpPWpGaD
Mianserin—DRD2—Signaling by GPCR—CXCL8—psoriasis	1.5e-05	0.000183	CbGpPWpGaD
Mianserin—ADRA2A—GPCR downstream signaling—CXCL8—psoriasis	1.48e-05	0.00018	CbGpPWpGaD
Mianserin—HTR2A—Signaling by GPCR—CXCL8—psoriasis	1.48e-05	0.00018	CbGpPWpGaD
Mianserin—HRH1—Signaling by GPCR—CXCL8—psoriasis	1.48e-05	0.000179	CbGpPWpGaD
Mianserin—ADRA2C—Signaling Pathways—LEP—psoriasis	1.47e-05	0.000179	CbGpPWpGaD
Mianserin—ADRA2C—Signaling Pathways—APOE—psoriasis	1.47e-05	0.000179	CbGpPWpGaD
Mianserin—ADRA2B—Signaling Pathways—NFKBIA—psoriasis	1.47e-05	0.000179	CbGpPWpGaD
Mianserin—HRH2—Signaling Pathways—VEGFA—psoriasis	1.45e-05	0.000176	CbGpPWpGaD
Mianserin—ADRA2A—Hemostasis—TP53—psoriasis	1.44e-05	0.000175	CbGpPWpGaD
Mianserin—HRH2—Signaling Pathways—STAT3—psoriasis	1.43e-05	0.000174	CbGpPWpGaD
Mianserin—HTR2B—Signaling Pathways—TYK2—psoriasis	1.43e-05	0.000174	CbGpPWpGaD
Mianserin—ADRA2A—Metabolism—APOE—psoriasis	1.43e-05	0.000174	CbGpPWpGaD
Mianserin—HTR1A—Signaling Pathways—NFKBIA—psoriasis	1.42e-05	0.000172	CbGpPWpGaD
Mianserin—HTR2C—Signaling Pathways—NFKBIA—psoriasis	1.41e-05	0.000171	CbGpPWpGaD
Mianserin—HRH4—Signaling Pathways—TP53—psoriasis	1.41e-05	0.000171	CbGpPWpGaD
Mianserin—OPRK1—Signaling Pathways—CXCL8—psoriasis	1.39e-05	0.000168	CbGpPWpGaD
Mianserin—ADRA2C—Signaling Pathways—NFKBIA—psoriasis	1.37e-05	0.000167	CbGpPWpGaD
Mianserin—HTR6—Signaling Pathways—CXCL8—psoriasis	1.37e-05	0.000166	CbGpPWpGaD
Mianserin—HTR7—Signaling Pathways—CXCL8—psoriasis	1.36e-05	0.000166	CbGpPWpGaD
Mianserin—HTR1D—Signaling Pathways—CXCL8—psoriasis	1.36e-05	0.000165	CbGpPWpGaD
Mianserin—ADRA2A—Signaling by GPCR—CXCL8—psoriasis	1.34e-05	0.000164	CbGpPWpGaD
Mianserin—CYP2B6—Metabolism—APOE—psoriasis	1.34e-05	0.000163	CbGpPWpGaD
Mianserin—DRD2—Signaling Pathways—LEP—psoriasis	1.34e-05	0.000162	CbGpPWpGaD
Mianserin—DRD2—Signaling Pathways—APOE—psoriasis	1.34e-05	0.000162	CbGpPWpGaD
Mianserin—DRD3—Signaling Pathways—TYK2—psoriasis	1.33e-05	0.000162	CbGpPWpGaD
Mianserin—OPRK1—Signaling by GPCR—IL6—psoriasis	1.32e-05	0.00016	CbGpPWpGaD
Mianserin—HTR2A—Signaling Pathways—LEP—psoriasis	1.31e-05	0.00016	CbGpPWpGaD
Mianserin—HTR2A—Signaling Pathways—APOE—psoriasis	1.31e-05	0.00016	CbGpPWpGaD
Mianserin—HRH1—Signaling Pathways—LEP—psoriasis	1.31e-05	0.000159	CbGpPWpGaD
Mianserin—HRH1—Signaling Pathways—APOE—psoriasis	1.31e-05	0.000159	CbGpPWpGaD
Mianserin—HTR1F—Signaling Pathways—TP53—psoriasis	1.3e-05	0.000158	CbGpPWpGaD
Mianserin—HTR6—Signaling by GPCR—IL6—psoriasis	1.3e-05	0.000158	CbGpPWpGaD
Mianserin—HTR7—Signaling by GPCR—IL6—psoriasis	1.3e-05	0.000158	CbGpPWpGaD
Mianserin—HRH4—Signaling Pathways—IL6—psoriasis	1.29e-05	0.000157	CbGpPWpGaD
Mianserin—HTR1D—Signaling by GPCR—IL6—psoriasis	1.29e-05	0.000157	CbGpPWpGaD
Mianserin—OPRK1—Signaling Pathways—JUN—psoriasis	1.29e-05	0.000157	CbGpPWpGaD
Mianserin—CYP3A4—Metabolism—CARM1—psoriasis	1.27e-05	0.000155	CbGpPWpGaD
Mianserin—HTR6—Signaling Pathways—JUN—psoriasis	1.27e-05	0.000154	CbGpPWpGaD
Mianserin—HTR7—Signaling Pathways—JUN—psoriasis	1.27e-05	0.000154	CbGpPWpGaD
Mianserin—HTR1D—Signaling Pathways—JUN—psoriasis	1.26e-05	0.000153	CbGpPWpGaD
Mianserin—HTR2B—Signaling Pathways—CXCL8—psoriasis	1.25e-05	0.000152	CbGpPWpGaD
Mianserin—ADRA2A—Metabolism—PPARG—psoriasis	1.25e-05	0.000151	CbGpPWpGaD
Mianserin—DRD2—Signaling Pathways—NFKBIA—psoriasis	1.24e-05	0.000151	CbGpPWpGaD
Mianserin—OPRK1—Signaling Pathways—NFKB1—psoriasis	1.24e-05	0.000151	CbGpPWpGaD
Mianserin—HTR2A—Signaling Pathways—NFKBIA—psoriasis	1.22e-05	0.000149	CbGpPWpGaD
Mianserin—HTR6—Signaling Pathways—NFKB1—psoriasis	1.22e-05	0.000149	CbGpPWpGaD
Mianserin—HRH1—Signaling Pathways—NFKBIA—psoriasis	1.22e-05	0.000149	CbGpPWpGaD
Mianserin—HTR7—Signaling Pathways—NFKB1—psoriasis	1.22e-05	0.000148	CbGpPWpGaD
Mianserin—HTR1D—Signaling Pathways—NFKB1—psoriasis	1.21e-05	0.000147	CbGpPWpGaD
Mianserin—ADRA2B—Signaling Pathways—TYK2—psoriasis	1.2e-05	0.000146	CbGpPWpGaD
Mianserin—CYP2D6—Metabolism—CAT—psoriasis	1.2e-05	0.000146	CbGpPWpGaD
Mianserin—ADRA2A—Signaling Pathways—APOE—psoriasis	1.2e-05	0.000145	CbGpPWpGaD
Mianserin—ADRA2A—Signaling Pathways—LEP—psoriasis	1.2e-05	0.000145	CbGpPWpGaD
Mianserin—HTR1F—Signaling Pathways—IL6—psoriasis	1.19e-05	0.000145	CbGpPWpGaD
Mianserin—HTR2B—Signaling by GPCR—IL6—psoriasis	1.19e-05	0.000144	CbGpPWpGaD
Mianserin—CYP2B6—Metabolism—PPARG—psoriasis	1.17e-05	0.000142	CbGpPWpGaD
Mianserin—HTR1A—Signaling Pathways—TYK2—psoriasis	1.16e-05	0.000141	CbGpPWpGaD
Mianserin—DRD3—Signaling Pathways—CXCL8—psoriasis	1.16e-05	0.000141	CbGpPWpGaD
Mianserin—HTR2B—Signaling Pathways—JUN—psoriasis	1.16e-05	0.000141	CbGpPWpGaD
Mianserin—HTR2C—Signaling Pathways—TYK2—psoriasis	1.16e-05	0.00014	CbGpPWpGaD
Mianserin—OPRK1—Signaling Pathways—VEGFA—psoriasis	1.13e-05	0.000137	CbGpPWpGaD
Mianserin—ADRA2C—Signaling Pathways—TYK2—psoriasis	1.12e-05	0.000137	CbGpPWpGaD
Mianserin—HTR2B—Signaling Pathways—NFKB1—psoriasis	1.12e-05	0.000136	CbGpPWpGaD
Mianserin—OPRK1—Signaling Pathways—STAT3—psoriasis	1.11e-05	0.000135	CbGpPWpGaD
Mianserin—ADRA2A—Signaling Pathways—NFKBIA—psoriasis	1.11e-05	0.000135	CbGpPWpGaD
Mianserin—HTR6—Signaling Pathways—VEGFA—psoriasis	1.11e-05	0.000135	CbGpPWpGaD
Mianserin—HTR7—Signaling Pathways—VEGFA—psoriasis	1.11e-05	0.000135	CbGpPWpGaD
Mianserin—DRD3—Signaling by GPCR—IL6—psoriasis	1.1e-05	0.000134	CbGpPWpGaD
Mianserin—HTR1D—Signaling Pathways—VEGFA—psoriasis	1.1e-05	0.000134	CbGpPWpGaD
Mianserin—HTR6—Signaling Pathways—STAT3—psoriasis	1.1e-05	0.000134	CbGpPWpGaD
Mianserin—HTR7—Signaling Pathways—STAT3—psoriasis	1.1e-05	0.000133	CbGpPWpGaD
Mianserin—HRH2—Signaling Pathways—TP53—psoriasis	1.09e-05	0.000133	CbGpPWpGaD
Mianserin—HTR1D—Signaling Pathways—STAT3—psoriasis	1.09e-05	0.000133	CbGpPWpGaD
Mianserin—DRD3—Signaling Pathways—JUN—psoriasis	1.08e-05	0.000131	CbGpPWpGaD
Mianserin—ADRA2B—Signaling Pathways—CXCL8—psoriasis	1.05e-05	0.000127	CbGpPWpGaD
Mianserin—DRD3—Signaling Pathways—NFKB1—psoriasis	1.04e-05	0.000126	CbGpPWpGaD
Mianserin—DRD2—Signaling Pathways—TYK2—psoriasis	1.02e-05	0.000124	CbGpPWpGaD
Mianserin—CYP1A2—Metabolism—CAT—psoriasis	1.02e-05	0.000124	CbGpPWpGaD
Mianserin—HTR2B—Signaling Pathways—VEGFA—psoriasis	1.01e-05	0.000123	CbGpPWpGaD
Mianserin—HTR1A—Signaling Pathways—CXCL8—psoriasis	1.01e-05	0.000123	CbGpPWpGaD
Mianserin—HTR2C—Signaling Pathways—CXCL8—psoriasis	1.01e-05	0.000122	CbGpPWpGaD
Mianserin—HTR2A—Signaling Pathways—TYK2—psoriasis	1e-05	0.000122	CbGpPWpGaD
Mianserin—HTR2B—Signaling Pathways—STAT3—psoriasis	1e-05	0.000122	CbGpPWpGaD
Mianserin—HRH1—Signaling Pathways—TYK2—psoriasis	1e-05	0.000122	CbGpPWpGaD
Mianserin—HRH2—Signaling Pathways—IL6—psoriasis	1e-05	0.000122	CbGpPWpGaD
Mianserin—ADRA2B—Signaling by GPCR—IL6—psoriasis	9.96e-06	0.000121	CbGpPWpGaD
Mianserin—ADRA2C—Signaling Pathways—CXCL8—psoriasis	9.78e-06	0.000119	CbGpPWpGaD
Mianserin—ADRA2B—Signaling Pathways—JUN—psoriasis	9.74e-06	0.000118	CbGpPWpGaD
Mianserin—HTR1A—Signaling by GPCR—IL6—psoriasis	9.61e-06	0.000117	CbGpPWpGaD
Mianserin—HTR2C—Signaling by GPCR—IL6—psoriasis	9.56e-06	0.000116	CbGpPWpGaD
Mianserin—DRD3—Signaling Pathways—VEGFA—psoriasis	9.42e-06	0.000115	CbGpPWpGaD
Mianserin—HTR1A—Signaling Pathways—JUN—psoriasis	9.4e-06	0.000114	CbGpPWpGaD
Mianserin—ADRA2B—Signaling Pathways—NFKB1—psoriasis	9.37e-06	0.000114	CbGpPWpGaD
Mianserin—HTR2C—Signaling Pathways—JUN—psoriasis	9.35e-06	0.000114	CbGpPWpGaD
Mianserin—DRD3—Signaling Pathways—STAT3—psoriasis	9.33e-06	0.000113	CbGpPWpGaD
Mianserin—CYP2D6—Metabolism—APOE—psoriasis	9.32e-06	0.000113	CbGpPWpGaD
Mianserin—ADRA2C—Signaling by GPCR—IL6—psoriasis	9.3e-06	0.000113	CbGpPWpGaD
Mianserin—ADRA2A—Signaling Pathways—TYK2—psoriasis	9.13e-06	0.000111	CbGpPWpGaD
Mianserin—ADRA2C—Signaling Pathways—JUN—psoriasis	9.09e-06	0.000111	CbGpPWpGaD
Mianserin—HTR1A—Signaling Pathways—NFKB1—psoriasis	9.05e-06	0.00011	CbGpPWpGaD
Mianserin—HTR2C—Signaling Pathways—NFKB1—psoriasis	9e-06	0.000109	CbGpPWpGaD
Mianserin—DRD2—Signaling Pathways—CXCL8—psoriasis	8.88e-06	0.000108	CbGpPWpGaD
Mianserin—ADRA2C—Signaling Pathways—NFKB1—psoriasis	8.75e-06	0.000106	CbGpPWpGaD
Mianserin—HTR2A—Signaling Pathways—CXCL8—psoriasis	8.73e-06	0.000106	CbGpPWpGaD
Mianserin—HRH1—Signaling Pathways—CXCL8—psoriasis	8.71e-06	0.000106	CbGpPWpGaD
Mianserin—ADRA2B—Signaling Pathways—VEGFA—psoriasis	8.51e-06	0.000103	CbGpPWpGaD
Mianserin—OPRK1—Signaling Pathways—TP53—psoriasis	8.5e-06	0.000103	CbGpPWpGaD
Mianserin—DRD2—Signaling by GPCR—IL6—psoriasis	8.44e-06	0.000103	CbGpPWpGaD
Mianserin—ADRA2B—Signaling Pathways—STAT3—psoriasis	8.42e-06	0.000102	CbGpPWpGaD
Mianserin—HTR6—Signaling Pathways—TP53—psoriasis	8.38e-06	0.000102	CbGpPWpGaD
Mianserin—HTR7—Signaling Pathways—TP53—psoriasis	8.37e-06	0.000102	CbGpPWpGaD
Mianserin—HTR1D—Signaling Pathways—TP53—psoriasis	8.32e-06	0.000101	CbGpPWpGaD
Mianserin—HTR2A—Signaling by GPCR—IL6—psoriasis	8.3e-06	0.000101	CbGpPWpGaD
Mianserin—HRH1—Signaling by GPCR—IL6—psoriasis	8.29e-06	0.000101	CbGpPWpGaD
Mianserin—DRD2—Signaling Pathways—JUN—psoriasis	8.25e-06	0.0001	CbGpPWpGaD
Mianserin—HTR1A—Signaling Pathways—VEGFA—psoriasis	8.21e-06	9.98e-05	CbGpPWpGaD
Mianserin—HTR2C—Signaling Pathways—VEGFA—psoriasis	8.17e-06	9.93e-05	CbGpPWpGaD
Mianserin—HTR1A—Signaling Pathways—STAT3—psoriasis	8.13e-06	9.88e-05	CbGpPWpGaD
Mianserin—HTR2A—Signaling Pathways—JUN—psoriasis	8.12e-06	9.87e-05	CbGpPWpGaD
Mianserin—CYP2D6—Metabolism—PPARG—psoriasis	8.12e-06	9.87e-05	CbGpPWpGaD
Mianserin—HRH1—Signaling Pathways—JUN—psoriasis	8.1e-06	9.85e-05	CbGpPWpGaD
Mianserin—HTR2C—Signaling Pathways—STAT3—psoriasis	8.09e-06	9.83e-05	CbGpPWpGaD
Mianserin—ADRA2A—Signaling Pathways—CXCL8—psoriasis	7.95e-06	9.66e-05	CbGpPWpGaD
Mianserin—ADRA2C—Signaling Pathways—VEGFA—psoriasis	7.94e-06	9.66e-05	CbGpPWpGaD
Mianserin—DRD2—Signaling Pathways—NFKB1—psoriasis	7.94e-06	9.66e-05	CbGpPWpGaD
Mianserin—CYP1A2—Metabolism—APOE—psoriasis	7.89e-06	9.6e-05	CbGpPWpGaD
Mianserin—ADRA2C—Signaling Pathways—STAT3—psoriasis	7.87e-06	9.56e-05	CbGpPWpGaD
Mianserin—CYP3A4—Metabolism—CAT—psoriasis	7.84e-06	9.53e-05	CbGpPWpGaD
Mianserin—HTR2A—Signaling Pathways—NFKB1—psoriasis	7.82e-06	9.5e-05	CbGpPWpGaD
Mianserin—HRH1—Signaling Pathways—NFKB1—psoriasis	7.8e-06	9.48e-05	CbGpPWpGaD
Mianserin—OPRK1—Signaling Pathways—IL6—psoriasis	7.78e-06	9.46e-05	CbGpPWpGaD
Mianserin—HTR6—Signaling Pathways—IL6—psoriasis	7.67e-06	9.33e-05	CbGpPWpGaD
Mianserin—HTR7—Signaling Pathways—IL6—psoriasis	7.66e-06	9.32e-05	CbGpPWpGaD
Mianserin—HTR2B—Signaling Pathways—TP53—psoriasis	7.65e-06	9.3e-05	CbGpPWpGaD
Mianserin—HTR1D—Signaling Pathways—IL6—psoriasis	7.61e-06	9.26e-05	CbGpPWpGaD
Mianserin—ADRA2A—Signaling by GPCR—IL6—psoriasis	7.56e-06	9.19e-05	CbGpPWpGaD
Mianserin—ADRA2A—Signaling Pathways—JUN—psoriasis	7.39e-06	8.98e-05	CbGpPWpGaD
Mianserin—DRD2—Signaling Pathways—VEGFA—psoriasis	7.21e-06	8.76e-05	CbGpPWpGaD
Mianserin—DRD2—Signaling Pathways—STAT3—psoriasis	7.14e-06	8.68e-05	CbGpPWpGaD
Mianserin—DRD3—Signaling Pathways—TP53—psoriasis	7.12e-06	8.65e-05	CbGpPWpGaD
Mianserin—ADRA2A—Signaling Pathways—NFKB1—psoriasis	7.11e-06	8.64e-05	CbGpPWpGaD
Mianserin—HTR2A—Signaling Pathways—VEGFA—psoriasis	7.09e-06	8.62e-05	CbGpPWpGaD
Mianserin—HRH1—Signaling Pathways—VEGFA—psoriasis	7.08e-06	8.6e-05	CbGpPWpGaD
Mianserin—HTR2A—Signaling Pathways—STAT3—psoriasis	7.02e-06	8.54e-05	CbGpPWpGaD
Mianserin—HRH1—Signaling Pathways—STAT3—psoriasis	7.01e-06	8.52e-05	CbGpPWpGaD
Mianserin—HTR2B—Signaling Pathways—IL6—psoriasis	7e-06	8.51e-05	CbGpPWpGaD
Mianserin—CYP1A2—Metabolism—PPARG—psoriasis	6.88e-06	8.36e-05	CbGpPWpGaD
Mianserin—DRD3—Signaling Pathways—IL6—psoriasis	6.52e-06	7.92e-05	CbGpPWpGaD
Mianserin—ADRA2A—Signaling Pathways—VEGFA—psoriasis	6.45e-06	7.85e-05	CbGpPWpGaD
Mianserin—ADRA2B—Signaling Pathways—TP53—psoriasis	6.43e-06	7.81e-05	CbGpPWpGaD
Mianserin—ADRA2A—Signaling Pathways—STAT3—psoriasis	6.39e-06	7.77e-05	CbGpPWpGaD
Mianserin—HTR1A—Signaling Pathways—TP53—psoriasis	6.2e-06	7.54e-05	CbGpPWpGaD
Mianserin—HTR2C—Signaling Pathways—TP53—psoriasis	6.17e-06	7.5e-05	CbGpPWpGaD
Mianserin—CYP3A4—Metabolism—APOE—psoriasis	6.09e-06	7.41e-05	CbGpPWpGaD
Mianserin—ADRA2C—Signaling Pathways—TP53—psoriasis	6e-06	7.3e-05	CbGpPWpGaD
Mianserin—ADRA2B—Signaling Pathways—IL6—psoriasis	5.88e-06	7.15e-05	CbGpPWpGaD
Mianserin—HTR1A—Signaling Pathways—IL6—psoriasis	5.68e-06	6.9e-05	CbGpPWpGaD
Mianserin—HTR2C—Signaling Pathways—IL6—psoriasis	5.65e-06	6.87e-05	CbGpPWpGaD
Mianserin—ADRA2C—Signaling Pathways—IL6—psoriasis	5.49e-06	6.68e-05	CbGpPWpGaD
Mianserin—DRD2—Signaling Pathways—TP53—psoriasis	5.45e-06	6.62e-05	CbGpPWpGaD
Mianserin—HTR2A—Signaling Pathways—TP53—psoriasis	5.36e-06	6.52e-05	CbGpPWpGaD
Mianserin—HRH1—Signaling Pathways—TP53—psoriasis	5.35e-06	6.5e-05	CbGpPWpGaD
Mianserin—CYP3A4—Metabolism—PPARG—psoriasis	5.31e-06	6.45e-05	CbGpPWpGaD
Mianserin—DRD2—Signaling Pathways—IL6—psoriasis	4.99e-06	6.06e-05	CbGpPWpGaD
Mianserin—HTR2A—Signaling Pathways—IL6—psoriasis	4.91e-06	5.96e-05	CbGpPWpGaD
Mianserin—HRH1—Signaling Pathways—IL6—psoriasis	4.9e-06	5.95e-05	CbGpPWpGaD
Mianserin—ADRA2A—Signaling Pathways—TP53—psoriasis	4.88e-06	5.93e-05	CbGpPWpGaD
Mianserin—ADRA2A—Signaling Pathways—IL6—psoriasis	4.46e-06	5.43e-05	CbGpPWpGaD
